Biblio Discovery — Demo Discovery Service

11 results for "Li-Chun Lu"

Showing 1–11 · 0.24 seconds · RSS

  1. Journal Article

    Recurrent Gastric Cancer Initially Presenting with Dysphagia induced by Idiopathic Inflammatory Myositis: A Case Report

    Che-Hao Chang; Li-Chun Lu

    Journal of Cancer Research and Practice, Vol. 11 No. 4 · 2024 · English · DOAJ

    We present the case of a 51-year-old female patient who was diagnosed with gastric cancer and subsequently underwent surgical resection, followed by adjuvant chemotherapy. Despite these interventions, the disease recurred, manifesting as laryngeal weakness and clinical features indicative of an…

  2. Journal Article

    Tumor Lysis Syndrome in a Super-responder to Chemoimmunotherapy for Nasopharyngeal Carcinoma: A Case Report

    Kuan-Yu Chen; Li-Chun Lu

    Journal of Cancer Research and Practice, Vol. 13 No. 2 · 2026 · English · DOAJ

    We present the case of a 54-year-old male with nasopharyngeal cancer accompanied by huge liver metastasis, an extremely high Epstein–Barr virus viral load, and B symptoms. Despite aggressive hydration and close laboratory monitoring, he developed tumor lysis syndrome (TLS) and acute kidney injury…

  3. Journal Article

    Unfavorable Tumor Responses to Immunotherapy in the Liver: Lessons Learned from Clinical and Preclinical Studies

    Li-Chun Lu; Gen-Sheng Feng; Chih-Hung Hsu

    Journal of Cancer Research and Practice, Vol. 10 No. 2 · 2023 · English · DOAJ

    Objective: Immunotherapy with immune checkpoint inhibitors (ICIs) has become a standard of care for many malignancies. The tumor microenvironment (TME) varies across different organs and affects tumor initiation, progression, and treatment outcomes. Organ-specific differential responses to ICIs…

  4. Journal Article

    Perivascular epithelioid cell tumor of the gastrointestinal tract

    Tsung-Hao Liu; Cher-Wei Liang; Li-Chun Lu

    Journal of Cancer Research and Practice, Vol. 3 No. 1 · 2016 · English · DOAJ

    Perivascular epithelioid cell tumor (PEComa) is a rare subtype of soft tissue sarcoma that coexpresses melanocytic and smooth muscle markers. We report a case of malignant PEComa arising from the gastrointestinal tract. Definitive diagnosis of malignant PEComa is based on pathological examination…

  5. Journal Article

    Shp2 Deficiency in Kupffer Cells and Hepatocytes Aggravates Hepatocarcinogenesis by Recruiting Non-Kupffer MacrophagesSummary

    Li Du; Yichun Ji; Bing Xin et al.

    Cellular and Molecular Gastroenterology and Hepatology, Vol. 15 No. 6 · 2023 · English · DOAJ Scopus

    Background & Aims: Complex communications between hepatocytes and Kupffer cells (KCs) are known to drive or suppress hepatocarcinogenesis, with controversial data in the literature. In previous experiments that aimed to decipher hepatocyte/KC interactions, we unexpectedly unveiled a…

  6. Journal Article

    Atezolizumab plus bevacizumab combination enables an unresectable hepatocellular carcinoma resectable and links immune exclusion and tumor dedifferentiation to acquired resistance

    Yulei Wang; Li-Chun Lu; Yinghui Guan et al.

    Experimental Hematology & Oncology, Vol. 10 No. 1 · 2021 · English · DOAJ Scopus

    Abstract We reported a patient with unresectable hepatocellular carcinoma (HCC) who initially received 15 cycles of atezolizumab plus bevacizumab combination and had best tumor response of partial response, but later experienced disease progression. After subsequent surgical resection, the patient…

  7. Journal Article

    Improved survival with adding-on strategy after failure of nanoliposomal irinotecan plus 5-fluorouracil and leucovorin in metastatic pancreatic adenocarcinoma

    Shih-Hung Yang; Chien-Jui Huang; Sz-Chi Chiu et al.

    Journal of the Formosan Medical Association, Vol. 125 No. 2 · 2026 · English · DOAJ Scopus

    Background: Nanoliposomal irinotecan (nal-IRI) plus 5-fluorouracil and leucovorin (FL) is indicated after progression on gemcitabine-based therapy in patients with metastatic pancreatic ductal adenocarcinoma (PDAC). However, salvage therapy after nal-IRI/FL failure remains to be established…

  8. Journal Article Full text

    Methodological Quality and Clinical Translation of Deep Learning in Traditional Chinese Medicine Disease Diagnosis: A Systematic Review and Validation Gap Analysis

    Li-Chun Lu; Han Li; Yu-Meng Liu et al.

    Information, Vol. 17 No. 6 · 2026 · English · DOAJ Scopus

    Traditional Chinese Medicine (TCM) diagnosis is characterized by substantial subjectivity and inter-practitioner variability. Although deep learning (DL) offers potential for standardization and intelligent diagnostic support, its methodological rigor and clinical applicability remain unclear. This…

  9. Journal Article

    Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma

    Shih-Hung Yang; Li-Chun Lu; Hsiang-Fong Kao et al.

    OncoImmunology, Vol. 10 No. 1 · 2021 · English · DOAJ Scopus

    Immune checkpoint inhibitors have limited efficacy in the treatment of pancreatic ductal adenocarcinoma (PDAC). We investigated prognostic markers for nivolumab-based therapy in advanced or recurrent PDAC. Consecutive patients receiving nivolumab-based therapy at our institution between 2015 and…

  10. Journal Article Full text

    DNA damage response pathway regulates Nrf2 in response to oxidative stress

    Jiang, Xiao-You; Guo, Qi-Qiang; Wang, Shan-Shan et al.

    Sci Adv · 2025 · English · PubMed Central

    Nrf2 acts as a transcriptional master regulator to orchestrate antioxidant responses and maintain redox balance. However, the cellular pathway for translating oxidative stress signals into Nrf2-dependent antioxidant responses remain incompletely understood. Here, we show that reactive oxygen…

  11. Journal Article

    Outcomes of post-immunotherapy durable responders of advanced hepatocellular carcinoma - with emphasis on locoregional therapy for oligoprogression

    Tsung-Hao Liu; San-Chi Chen; Kun-Ming Rau et al.

    Liver Cancer (2024) · 2024 · English · DOAJ Scopus

    Introduction The progression patterns, dispositions, and outcomes of patients with advanced hepatocellular carcinoma (HCC) who achieved durable responses with immunotherapy remain poorly characterized. Methods Patients with advanced HCC who received immune checkpoint inhibitor (ICI)-based…